Sonnet BioTherapeutics HoldingsSONN 
$0.71-2.74%24h
-2.74%24h
Global rank36043
Market cap$737.11K
Change 7d2.90%
YTD Performance-59.20%
SP500 benchmarkUnderperform
P/E-0.04
P/S4.99
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings SONN Total Debt
SONN Total Debt in 2022: $130.86K
According to Sonnet BioTherapeutics Holdings latest financial reports the total debt is $130.86K, an decrease of -35.82% to 2022. At the end of 2022 company had $203.91K total debt. This figure represents the debts and financial obligations that Sonnet BioTherapeutics Holdings combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Sonnet BioTherapeutics Holdings SONN Total Debt History from 2023 to 2022
-
Value:-
SONN Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $130.86K | -35.82% |
| 2022 | $203.91K | 566.12% |
| 2021 | $30.61K | -87.76% |
| 2020 | $250.01K | Infinity% |
| 2019 | $0 | - |
View the Top Total Debt Stocks 
